Literature DB >> 25451674

[Non-targeted effects (bystander, abscopal) of external beam radiation therapy: an overview for the clinician].

R Sun1, A Sbai2, G Ganem3, M Boudabous4, F Collin5, P-Y Marcy6, A Doglio7, J Thariat8.   

Abstract

Radiotherapy is advocated in the treatment of cancer of over 50 % of patients. It has long been considered as a focal treatment only. However, the observation of effects, such as fatigue and lymphopenia, suggests that systemic effects may also occur. The description of bystander and abscopal effects suggests that irradiated cells may exert an action on nearby or distant unirradiated cells, respectively. A third type of effect that involves feedback interactions between irradiated cells was more recently described (cohort effect). This new field of radiation therapy is yet poorly understood and the definitions suffer from a lack of reproducibility in part due to the variety of experimental models. The bystander effect might induce genomic instability in non-irradiated cells and is thus extensively studied for a potential risk of radiation-induced cancer. From a therapeutic perspective, reproducing an abscopal effect by using a synergy between ionizing radiation and immunomodulatory agents to elicit or boost anticancer immune responses is an interesting area of research. Many applications are being developed in particular in the field of hypofractionated stereotactic irradiation of metastatic disease.
Copyright © 2014 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Abscopal; Bystander; Cellular communication; Cohorte; Communication cellulaire; Distance; Distant or abscopal effect, cohort effect; Effet; Immunity; Immunité; Local bystander effect; Long-range bystander; Systémique; Tumeur; Tumor

Mesh:

Year:  2014        PMID: 25451674     DOI: 10.1016/j.canrad.2014.08.004

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Radionuclide Therapy of Unresectable Tumors with AvidinOX and (90)Y-biotinDOTA: Tongue Cancer Paradigm.

Authors:  Claudio Albertoni; Barbara Leoni; Antonio Rosi; Valeria D'Alessio; Valeria Carollo; Luigi Giusto Spagnoli; Cees van Echteld; Rita De Santis
Journal:  Cancer Biother Radiopharm       Date:  2015-07-13       Impact factor: 3.099

2.  Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin.

Authors:  Christian Ostheimer; Sophie Gunther; Matthias Bache; Dirk Vordermark; Gabriele Multhoff
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

Review 3.  Radiation-induced bystander and abscopal effects: important lessons from preclinical models.

Authors:  Elisabeth Daguenet; Safa Louati; Anne-Sophie Wozny; Nicolas Vial; Mathilde Gras; Jean-Baptiste Guy; Alexis Vallard; Claire Rodriguez-Lafrasse; Nicolas Magné
Journal:  Br J Cancer       Date:  2020-06-25       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.